• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压患者心内膜下灌注与心肌损伤、心脏结构和临床结局的关系。

Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.

机构信息

Zhejiang University School of Medicine, Hangzhou, China (X.X., L.Z.).

Cardiovascular Imaging Program, Departments of Medicine and Radiology (X.X., S. Divakaran, B.N.W., J.H., S.S.L., B.A., M.F.K., R.B., S. Dorbala, J.M.B., M.F.D.C.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

出版信息

Circulation. 2024 Oct;150(14):1075-1086. doi: 10.1161/CIRCULATIONAHA.123.067083. Epub 2024 Aug 21.

DOI:10.1161/CIRCULATIONAHA.123.067083
PMID:39166326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11526823/
Abstract

BACKGROUND

Coronary microvascular dysfunction has been implicated in the development of hypertensive heart disease and heart failure, with subendocardial ischemia identified as a driver of sustained myocardial injury and fibrosis. We aimed to evaluate the relationships of subendocardial perfusion with cardiac injury, structure, and a composite of major adverse cardiac and cerebrovascular events consisting of death, heart failure hospitalization, myocardial infarction, and stroke.

METHODS

Layer-specific blood flow and myocardial flow reserve (MFR; stress/rest myocardial blood flow) were assessed by N-ammonia perfusion positron emission tomography in consecutive patients with hypertension without flow-limiting coronary artery disease (summed stress score <3) imaged at Brigham and Women's Hospital (Boston, MA) from 2015 to 2021. In this post hoc observational study, biomarkers, echocardiographic parameters, and longitudinal clinical outcomes were compared by tertiles of subendocardial MFR (MFR).

RESULTS

Among 358 patients, the mean age was 70.6±12.0 years, and 53.4% were male. The median MFR was 2.57 (interquartile range, 2.08-3.10), and lower MFR was associated with older age, diabetes, lower renal function, greater coronary calcium burden, and higher systolic blood pressure (<0.05 for all). In cross-sectional multivariable regression analyses, the lowest tertile of MFR was associated with myocardial injury and with greater left ventricular wall thickness and volumes compared with the highest tertile. Relative to the highest tertile, low MFR was independently associated with an increased rate of major adverse cardiac and cerebrovascular events (adjusted hazard ratio, 2.99 [95% CI, 1.39-6.44]; =0.005) and heart failure hospitalization (adjusted hazard ratio, 2.76 [95% CI, 1.04-7.32; =0.042) over 1.1 (interquartile range, 0.6-2.8) years median follow-up.

CONCLUSIONS

Among patients with hypertension without flow-limiting coronary artery disease, impaired MFR was associated with cardiovascular risk factors, elevated cardiac biomarkers, cardiac structure, and clinical events.

摘要

背景

冠状动脉微血管功能障碍与高血压性心脏病和心力衰竭的发展有关,其中心内膜下缺血被认为是持续心肌损伤和纤维化的驱动因素。我们旨在评估心内膜下灌注与心脏损伤、结构以及由死亡、心力衰竭住院、心肌梗死和中风组成的主要不良心脏和脑血管事件的复合事件的关系。

方法

2015 年至 2021 年,在布莱根妇女医院(波士顿,MA)连续成像的无限制冠状动脉疾病(总和应激评分<3)的高血压患者中,通过 N-氨灌注正电子发射断层扫描评估层特异性血流和心肌血流储备(应激/休息心肌血流)。在这项事后观察性研究中,根据心内膜下 MFR(MFR)的三分位数,比较生物标志物、超声心动图参数和纵向临床结局。

结果

在 358 例患者中,平均年龄为 70.6±12.0 岁,53.4%为男性。中位 MFR 为 2.57(四分位距,2.08-3.10),较低的 MFR与年龄较大、糖尿病、较低的肾功能、更高的冠状动脉钙负荷和更高的收缩压有关(所有<0.05)。在横断面多变量回归分析中,MFR 的最低三分位数与心肌损伤以及与左心室壁厚度和体积较大相关。与最高三分位数相比,低 MFR 与主要不良心脏和脑血管事件(调整后的危险比,2.99[95%CI,1.39-6.44];=0.005)和心力衰竭住院(调整后的危险比,2.76[95%CI,1.04-7.32;=0.042)的发生率增加独立相关,中位随访 1.1(四分位距,0.6-2.8)年。

结论

在无限制冠状动脉疾病的高血压患者中,MFR 受损与心血管危险因素、升高的心脏生物标志物、心脏结构和临床事件相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/27fdea4c3d5e/nihms-2015924-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/e5a4c3a2b235/nihms-2015924-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/258af43d4c7b/nihms-2015924-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/f91a04d8437d/nihms-2015924-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/27fdea4c3d5e/nihms-2015924-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/e5a4c3a2b235/nihms-2015924-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/258af43d4c7b/nihms-2015924-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/f91a04d8437d/nihms-2015924-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b6/11526823/27fdea4c3d5e/nihms-2015924-f0004.jpg

相似文献

1
Relationship of Subendocardial Perfusion to Myocardial Injury, Cardiac Structure, and Clinical Outcomes Among Patients With Hypertension.高血压患者心内膜下灌注与心肌损伤、心脏结构和临床结局的关系。
Circulation. 2024 Oct;150(14):1075-1086. doi: 10.1161/CIRCULATIONAHA.123.067083. Epub 2024 Aug 21.
2
Impaired myocardial perfusion is associated with increasing end-systolic- and end-diastolic volumes in patients with non-ischemic systolic heart failure: a cross-sectional study using Rubidium-82 PET/CT.非缺血性收缩性心力衰竭患者心肌灌注受损与收缩末期和舒张末期容积增加相关:一项使用铷-82 PET/CT的横断面研究
BMC Cardiovasc Disord. 2019 Mar 22;19(1):68. doi: 10.1186/s12872-019-1047-x.
3
Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease.与心肌质量相比,冠状动脉血流低可预测无阻塞性冠状动脉疾病的有症状高血压患者发生心力衰竭。
Eur Heart J. 2022 Sep 14;43(35):3323-3331. doi: 10.1093/eurheartj/ehab610.
4
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.慢性肾脏损伤患者的冠状动脉微血管功能障碍、左心室重构和临床转归。
Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.
5
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis: The Microvascular Disease in Aortic Stenosis (MIDAS) Study.主动脉瓣狭窄患者心肌血流储备与不良左心室重构的相关性:主动脉瓣狭窄中的微血管疾病(MIDAS)研究。
JAMA Cardiol. 2022 Jan 1;7(1):93-99. doi: 10.1001/jamacardio.2021.3396.
6
Prognostic implications of myocardial perfusion imaging by 82-rubidium positron emission tomography in male and female patients with angina and no perfusion defects.82 铷正电子发射断层扫描心肌灌注显像对有或无灌注缺损的心绞痛男性和女性患者的预后意义。
Eur Heart J Cardiovasc Imaging. 2023 Jan 23;24(2):212-222. doi: 10.1093/ehjci/jeac217.
7
Prognostic value of myocardial flow reserve vs corrected myocardial flow reserve in patients without obstructive coronary artery disease.无阻塞性冠状动脉疾病患者中心肌血流储备与校正心肌血流储备的预后价值。
J Nucl Cardiol. 2024 Jul;37:101854. doi: 10.1016/j.nuclcard.2024.101854. Epub 2024 Apr 7.
8
Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.高血压性冠状动脉微血管功能障碍:终末器官损害和心力衰竭的亚临床标志物。
Eur Heart J. 2020 Jul 1;41(25):2366-2375. doi: 10.1093/eurheartj/ehaa191.
9
Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.在无明显冠状动脉疾病的患者中,受损的冠状动脉血流储备与心肌细胞损伤对不良心血管结局的相互作用。
Circulation. 2015 Feb 10;131(6):528-35. doi: 10.1161/CIRCULATIONAHA.114.009716. Epub 2014 Dec 5.
10
Coronary vasomotor dysfunction portends worse outcomes in patients with breast cancer.冠状动脉血管运动功能障碍预示着乳腺癌患者的预后更差。
J Nucl Cardiol. 2022 Dec;29(6):3072-3081. doi: 10.1007/s12350-021-02825-1. Epub 2021 Nov 24.

引用本文的文献

1
Causal effect of systolic blood pressure on myocardial injury and mortality: insights from Mendelian randomization and a prospective group study.收缩压对心肌损伤和死亡率的因果效应:孟德尔随机化和前瞻性队列研究的见解
Mol Cell Biochem. 2025 Aug 20. doi: 10.1007/s11010-025-05373-1.
2
Nomogram for predicting the 28-day mortality risk of patients with subendocardial infarction.预测心内膜下梗死患者28天死亡风险的列线图。
Front Cardiovasc Med. 2025 Jun 13;12:1459855. doi: 10.3389/fcvm.2025.1459855. eCollection 2025.
3
Subendocardial quantification enhances coronary artery disease detection in F-flurpiridaz PET.

本文引用的文献

1
Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.美国患有和不患有糖尿病的成年人亚临床心血管疾病。
J Am Heart Assoc. 2023 Jun 6;12(11):e029083. doi: 10.1161/JAHA.122.029083. Epub 2023 May 31.
2
Myocardial Perfusion PET for the Detection and Reporting of Coronary Microvascular Dysfunction: A JACC: Cardiovascular Imaging Expert Panel Statement.用于检测和报告冠状动脉微血管功能障碍的心肌灌注正电子发射断层显像:美国心脏病学会杂志:心血管影像专家小组声明
JACC Cardiovasc Imaging. 2023 Apr;16(4):536-548. doi: 10.1016/j.jcmg.2022.12.015. Epub 2023 Feb 8.
3
Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes With and Without Revascularization.
心内膜下定量分析可提高F-氟吡哒嗪PET对冠状动脉疾病的检测能力。
Eur J Nucl Med Mol Imaging. 2025 Mar 5. doi: 10.1007/s00259-025-07174-6.
4
Acute cardiovascular responses to the 100-mi Western States Endurance Run.对100英里西部各州耐力跑的急性心血管反应。
J Appl Physiol (1985). 2024 Nov 1;137(5):1257-1266. doi: 10.1152/japplphysiol.00412.2024. Epub 2024 Sep 19.
心内膜下和透壁性心肌缺血:有或无血运重建情况下的临床特征、患病率及预后
JACC Cardiovasc Imaging. 2023 Jan;16(1):78-94. doi: 10.1016/j.jcmg.2022.05.016. Epub 2022 Sep 14.
4
Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者微血管功能障碍的患病率及预后意义
JACC Cardiovasc Imaging. 2022 Jun;15(6):1001-1011. doi: 10.1016/j.jcmg.2021.11.022. Epub 2022 Jan 12.
5
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.新型基于肌酐和胱抑素 C 的估算肾小球滤过率方程,无需考虑种族因素。
N Engl J Med. 2021 Nov 4;385(19):1737-1749. doi: 10.1056/NEJMoa2102953. Epub 2021 Sep 23.
6
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者中的冠状动脉疾病和冠状动脉微血管功能障碍的患病率。
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143. doi: 10.1001/jamacardio.2021.1825.
7
Coronary microvascular dysfunction in hypertrophic cardiomyopathy: Pathophysiology, assessment, and clinical impact.肥厚型心肌病中的冠状动脉微血管功能障碍:病理生理学、评估和临床影响。
Microcirculation. 2021 Jan;28(1):e12656. doi: 10.1111/micc.12656. Epub 2020 Sep 22.
8
Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure.高血压性冠状动脉微血管功能障碍:终末器官损害和心力衰竭的亚临床标志物。
Eur Heart J. 2020 Jul 1;41(25):2366-2375. doi: 10.1093/eurheartj/ehaa191.
9
Coronary microvascular dysfunction in hypertrophy and heart failure.肥厚型心肌病和心力衰竭中的冠状动脉微血管功能障碍。
Cardiovasc Res. 2020 Mar 1;116(4):806-816. doi: 10.1093/cvr/cvaa023.
10
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.慢性肾脏损伤患者的冠状动脉微血管功能障碍、左心室重构和临床转归。
Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.